文献速递生殖医学

卵巢成熟异常女性黄体期与卵泡期体外成熟的比较

Comparison of luteal phase and follicular phase in-vitro maturation in women with oocyte maturation abnormalities.
PubMed 文献 · Reprod Biomed Online · 2023-10-29

回顾性队列研究比较卵巢成熟异常(OMA)女性黄体期与卵泡期体外成熟(IVM)的结局。黄体期组与卵泡期组在卵母细胞成熟率、受精率、胚胎等级及妊娠率上均无显著差异;同一月经周期内两种方案的9例患者中,中期II卵母细胞成熟率亦无差异。

要点

  • 黄体期IVM与卵泡期IVM在OMA女性中的卵母细胞成熟、受精、胚胎质量及妊娠结局均无显著差异。
  • 取卵后48小时每患者中期II卵母细胞率黄体期组22.5%(IQR 0.0-52.9%)与卵泡期组40.0%(IQR 0.0-66.7%)相当(P = 0.53)。
  • 同一月经周期内比较两种方案时,中期II卵母细胞成熟率无差异(P > 0.05)。

核心结论

  • 黄体期IVM与卵泡期IVM在OMA女性中的卵母细胞成熟、受精率、胚胎质量或妊娠结局均无显著差异。
  • 作者认为黄体期IVM可类似卵泡期IVM使用,为OMA女性增加胚胎产出提供潜在途径。

研究设计与样本

  • 2019年1月至2023年5月在一家私立IVF中心开展的回顾性队列研究。
  • 第1组(卵泡期)36名女性共53个IVM周期;第2组(黄体期)24名女性共32个IVM周期。
  • 另有9名女性同时接受卵泡期和黄体期IVM周期,用于周期内变异性分析。

主要发现

  • 取卵时两组的卵母细胞成熟阶段无差异。
  • 取卵后48小时每患者中期II卵母细胞率:第1组40.0%(IQR 0.0-66.7%)vs 第2组22.5%(IQR 0.0-52.9%)(P = 0.53)。
  • 受精率中位数:第1组66.7%(IQR 50.0-66.7%)与第2组66.7%(IQR 50.0-66.7%)相当。
  • 两组的胚胎等级和妊娠率无显著差异。
  • 9名患者同一月经周期内卵泡期与黄体期IVM比较,中期II卵母细胞成熟率无差异(P > 0.05)。

临床怎么用

  • 作者认为黄体期IVM可类似卵泡期IVM使用,为OMA女性增加胚胎产出提供潜在途径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Are there differences in immature oocyte retrieval following luteal phase in-vitro maturation (IVM) compared with follicular phase IVM in women with oocyte maturation abnormalities (OMAs). DESIGN: From January 2019 to May 2023, a retrospective cohort study at a private IVF centre included 36 women with 53 IVM cycles in Group 1 (follicular phase) and 24 women with 32 IVM cycles in Group 2 (luteal phase). Additionally, nine women had both follicular and luteal phase IVM cycles for intracycle variability analysis. RESULTS: There were no differences in oocyte maturation stages between the groups at collection. Group 1 and Group 2 exhibited comparable median metaphase II oocyte rates per patient at 48 h after collection [40.0%, interquartile range (IQR) 0.0-66.7% versus 22.5%, IQR 0.0-52.9%] (P = 0.53). The median fertilization rate in Group 1 (66.7%, IQR 50.0-66.7%) was found to be comparable with that in Group 2 (66.7%, IQR 50.0-66.7%). There were no significant differences in the yielded embryo grades and pregnancy rates between the groups. Comparing follicular and luteal phase IVM within the same menstrual cycle in nine patients, no differences were observed in metaphase II oocyte maturation rates (P > 0.05). CONCLUSIONS: This study found no significant differences in oocyte maturation, fertilization rate, embryo quality or pregnancy outcomes between luteal phase and follicular phase IVM in women with OMAs. These findings suggest that luteal phase IVM can be used similarly to follicular phase IVM, offering a potential avenue to enhance embryo yield for women with OMAs.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hatirnaz Ş, Hatirnaz E, Urkmez SS, et al. Comparison of luteal phase and follicular phase in-vitro maturation in women with oocyte maturation abnormalities. Reprod Biomed Online. 2023. PMID: 38364519. doi:10.1016/j.rbmo.2023.103648

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。